Print Page     Close Window     

Events & Presentations

October 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. Please select a highlighted date from the calendar to see date-specific company information, including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SMTWTFS
1234567
891011121314
15161718
Oct 18, 2017
ESGCT 2017 OTC Poster
Formats:  PDF
ESGCT 2017 MMA Poster
Formats:  PDF
192021
22232425262728
29303151525354
Calendar Instructions
Please select a highlighted date from the calendar to view company related information. This calendar requires JavaScript to be installed and activated on your browser.
Presentations
DateTitleFormat/Plug-in Support
Oct 18, 2017
ESGCT 2017 OTC Poster
Download Documentation
PDF
Oct 18, 2017
ESGCT 2017 MMA Poster
Download Documentation
PDF
Sep 12, 2017
Selecta September 2017 Investor Presentation
Download Documentation
PDF
Upcoming Events
There are currently no events scheduled.
Past Events
DateTitle
Sep 27, 2017
Selecta Biosciences Inc at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
Sep 26, 2017 9:10 a.m. ET
Selecta Biosciences Inc at the 2017 Cantor Fitzgerald Global Healthcare Conference
Aug 11, 2017 8:30 a.m. ET
Q2 2017 Selecta Biosciences Inc Earnings Conference Call
Aug 09, 2017 12:00 p.m. ET
Selecta Biosciences Inc at the Canaccord Genuity 37th Annual Growth Conference

Safe Harbor Statement

Any statements in any event or presentation about the future expectations, plans and prospects of Selecta Biosciences, Inc. ("the company"), including without limitation, statements containing the words "anticipate," "believe," "continue," "could," "estimate," "expect," "hypothesize," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "would," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including, but not limited to, those discussed in the "Risk Factors" section of the company's most recent periodic report, i.e., 10-K or 10-Q, filed with the Securities and Exchange Commission, or SEC, and in other filings that the company makes with the SEC.

In addition, any forward-looking statements included in any event or presentation represent the company's views only as of the date of such event or presentation and should not be relied upon as representing its views as of any subsequent date. The company specifically disclaims any obligation to update any forward-looking statements included in any event or presentation.

AcceptDecline

© Selecta Biosciences, Inc. All rights reserved.